Drug Kinetics – News and Features

Using the microrobots, the team successfully delivered therapeutics that decreased the size of bladder tumors in mice.

This article explores some of the challenges in developing cell lines for therapeutics, such as cell line stability, and how they are being addressed.

As the field of oligonucleotide therapeutics continues to evolve, the integration of robust analytical tools will be essential in advancing personalized medicine and improving patient outcomes across a wide range of diseases.

A new shape-changing polymer that can move in several directions could transform how soft materials and soft robots are constructed.

Oregon State researchers discovered that exposing a copper-based MOF to ammonia gas doubles its CO2 adsorption ability. This method enhances carbon capture efficiency without increasing regeneration energy.

Researchers have developed programmable DNA nanostructures using DNA origami. These customizable nanobots have vast applications, from targeted drug delivery and adaptive materials to energy-efficient optical systems.

A tiny, four-fingered “hand” folded from a single piece of DNA can pick up the virus that causes COVID-19 for highly sensitive rapid detection and can even block viral particles from entering cells to infect them.

A study reveals that gut bacteria impact tamoxifen’s effectiveness in breast cancer treatment. Certain bacterial enzymes enhance the drug's recycling into the bloodstream, improving its efficacy.

A Mount Sinai team has developed a blood-brain barrier-crossing conjugate (BCC) platform, enabling therapeutic molecules to target the brain. The system effectively silenced disease-related genes like Sod1 in ALS and Mapt in Alzheimer’s.

This article explores the difficulties faced in attempting to treat HIV, an innovative prevention strategy and the possibility of a cure.